Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands

Journal of Medicinal Chemistry
2005.0

Abstract

Structural modification of salvinorin A, the active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study a nonnitrogenous neoclerodane diterpene with mu opioid receptor affinity (13) that is an agonist at mu opioid receptors. This represents the identification of a novel structural class of mu opioid receptor agonists.

Knowledge Graph

Similar Paper

Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands
Journal of Medicinal Chemistry 2005.0
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum:  Preparation and Opioid Receptor Activity of Salvinicin Analogues
Journal of Medicinal Chemistry 2007.0
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum:  Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A
Journal of Natural Products 2006.0
Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
Journal of Medicinal Chemistry 2014.0
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: Exploration of the 1-position
Bioorganic & Medicinal Chemistry Letters 2007.0
Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor
European Journal of Medicinal Chemistry 2014.0
Thermal degradation products derived from the smoke of Salvia divinorum leaves
Tetrahedron Letters 2010.0
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: Selective modification of the furan ring
Bioorganic & Medicinal Chemistry Letters 2006.0
Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability
Journal of Medicinal Chemistry 2016.0